New drug, promising breakthrough for incurable neurodegenerative myelin diseases – Neuroscience News
Summary: Riluzole, an FDA-approved drug to treat ALS, may, in part, correct the molecular cause of some leukodystrophies. Source: Montreal university There is new hope for the future treatment of certain leukodystrophies, neurodegenerative diseases in young children that progressively affect their quality of life, often leading to death before adulthood. The development stems from the …
